ReShape Lifesciences (RSLS) has had the highest return since April 1, 2025 by a micro-cap US stock, returning 92.1%.
| ASSET | % RETURN |
|---|---|
ReShape Lifesciences (RSLS) | 92.05% |
bioAffinity Technologies (BIAF) | 57.99% |
QuantaSing Group Limited American Depositary Shares (QSG) | 50.92% |
Alaunos Therapeutics (TCRT) | 50% |
iCoreConnect Inc Common stock (ICCT) | 49.37% |
Protagenic Therapeutics (PTIX) | 39.66% |
Petros Pharmaceuticals (PTPI) | 35.48% |
LanzaTech Global (LNZA) | 30.24% |
ATI Physical Therapy (ATIP) | 30% |
Moving iMage Technologies (MITQ) | 28.93% |
Adaptimmune Therapeutics (ADAP) | 28.14% |
GlucoTrack (GCTK) | 27.84% |
GD Culture (GDC) | 26.29% |
Nxu (NXU) | 26.28% |
Planet Green (PLAG) | 25.21% |
Equillium (EQ) | 25.01% |
Energy Vault (NRGV) | 24.82% |
Tupperware Brands (TUPBQ) | 24.75% |
Leishen Energy Holding Co, Ltd Ordinary Shares (LSE) | 23.7% |
iSpecimen (ISPC) | 23.58% |
cbdMD (YCBD) | 23.33% |
Powell Max Limited Class A Ordinary Shares (PMAX) | 21.26% |
TNF Pharmaceuticals (TNFA) | 21.07% |
Adagene (ADAG) | 19.41% |
PicoCELA Inc American Depositary Shares (PCLA) | 18.91% |
Micro-cap stocks are treated as having a market cap of <= $300M.
